Views

CrossRef citations to date

Altmetric

Letters

When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis

W-H Yoo1 Department of Internal Medicine, Division of Rheumatology, Jeonbuk National University Medical School, Jeonju, South Korea;2 Research Institute of Clinical Medicine of Jeonbuk National University – Biomedical Research Institute, Jeonbuk National University, Jeonju, South Korea

https://orcid.org/0000-0002-8430-7629 View further author information

GW Ha2 Research Institute of Clinical Medicine of Jeonbuk National University – Biomedical Research Institute, Jeonbuk National University, Jeonju, South Korea;3 Department of Surgery, Jeonbuk National University Medical School, Jeonju, South Korea

https://orcid.org/0000-0001-9401-1760 View further author information

KM Kim2 Research Institute of Clinical Medicine of Jeonbuk National University – Biomedical Research Institute, Jeonbuk National University, Jeonju, South Korea;4 Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea

https://orcid.org/0000-0001-7074-7183 View further author information

Y Choi1 Department of Internal Medicine, Division of Rheumatology, Jeonbuk National University Medical School, Jeonju, South Korea;2 Research Institute of Clinical Medicine of Jeonbuk National University – Biomedical Research Institute, Jeonbuk National University, Jeonju, South KoreaCorrespondence[email protected]

https://orcid.org/0000-0002-7922-0705 View further author information

Click to increase image sizeClick to decrease image size

Disclosure statement

No potential conflict of interest was reported by the authors.

Ethics statement

The present study was approved by the Institutional Review Board of Jeonbuk National University Hospital (JNUH 2023-10-004). The study was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from the patient for the publication of this report.

Additional information

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government Ministry of Science and ICT [no. 2021R1G1A1094571] and by the Research Base Construction Fund Support Program funded by Jeonbuk National Universitys in 2023.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis

Information for

Open access

Opportunities

Help and information

When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis

Disclosure statement

Ethics statement

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature